Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 135

1.

Disparities in uptake of 13-valent pneumococcal conjugate vaccine among older adults in the United States.

McLaughlin JM, Swerdlow DL, Khan F, Will O, Curry A, Snow V, Isturiz RE, Jodar L.

Hum Vaccin Immunother. 2019;15(4):841-849. doi: 10.1080/21645515.2018.1564434. Epub 2019 Feb 22.

2.

Acute otitis media, antimicrobial prescriptions, and medical expenses among children in the United States during 2011-2016.

Suaya JA, Gessner BD, Fung S, Vuocolo S, Scaife J, Swerdlow DL, Isturiz RE, Arguedas AG.

Vaccine. 2018 Nov 26;36(49):7479-7486. doi: 10.1016/j.vaccine.2018.10.060. Epub 2018 Oct 24.

3.

Decision-making for PCV in adults.

McLaughlin JM, Swerdlow DL, Isturiz RE, Jodar L.

Hum Vaccin Immunother. 2019;15(3):584-593. doi: 10.1080/21645515.2018.1538611. Epub 2018 Dec 10.

4.

Effectiveness of 13-Valent Pneumococcal Conjugate Vaccine Against Hospitalization for Community-Acquired Pneumonia in Older US Adults: A Test-Negative Design.

McLaughlin JM, Jiang Q, Isturiz RE, Sings HL, Swerdlow DL, Gessner BD, Carrico RM, Peyrani P, Wiemken TL, Mattingly WA, Ramirez JA, Jodar L.

Clin Infect Dis. 2018 Oct 30;67(10):1498-1506. doi: 10.1093/cid/ciy312.

5.

Prevalence of Helicobacter pylori among Alaskans: Factors associated with infection and comparison of urea breath test and anti-Helicobacter pylori IgG antibodies.

Miernyk KM, Bulkow LR, Gold BD, Bruce MG, Hurlburt DH, Griffin PM, Swerdlow DL, Cook K, Hennessy TW, Parkinson AJ.

Helicobacter. 2018 Jun;23(3):e12482. doi: 10.1111/hel.12482. Epub 2018 Mar 14.

PMID:
29537130
6.

Rethinking number-needed-to-vaccinate for pneumococcal conjugate vaccines in older adults: Current and future implications.

McLaughlin JM, Swerdlow DL, Isturiz RE, Jodar L.

Vaccine. 2017 Sep 25;35(40):5360-5365. doi: 10.1016/j.vaccine.2017.08.028. Epub 2017 Aug 31.

PMID:
28863866
7.

Risk Factors for Middle East Respiratory Syndrome Coronavirus Infection among Healthcare Personnel.

Alraddadi BM, Al-Salmi HS, Jacobs-Slifka K, Slayton RB, Estivariz CF, Geller AI, Al-Turkistani HH, Al-Rehily SS, Alserehi HA, Wali GY, Alshukairi AN, Azhar EI, Haynes L, Swerdlow DL, Jernigan JA, Madani TA.

Emerg Infect Dis. 2016 Nov;22(11):1915-1920. doi: 10.3201/eid2211.160920.

8.

Estimation of Severe Middle East Respiratory Syndrome Cases in the Middle East, 2012-2016.

O'Hagan JJ, Carias C, Rudd JM, Pham HT, Haber Y, Pesik N, Cetron MS, Gambhir M, Gerber SI, Swerdlow DL.

Emerg Infect Dis. 2016 Oct;22(10):1797-9. doi: 10.3201/2210.151121.

9.

Exportations of Symptomatic Cases of MERS-CoV Infection to Countries outside the Middle East.

Carias C, O'Hagan JJ, Jewett A, Gambhir M, Cohen NJ, Haber Y, Pesik N, Swerdlow DL.

Emerg Infect Dis. 2016 Apr;22(4):723-5.

10.

Middle East Respiratory Syndrome (MERS).

Rasmussen SA, Watson AK, Swerdlow DL.

Microbiol Spectr. 2016 Jun;4(3). doi: 10.1128/microbiolspec.EI10-0020-2016. Review.

PMID:
27337460
11.

Outbreak of Middle East Respiratory Syndrome at Tertiary Care Hospital, Jeddah, Saudi Arabia, 2014.

Hastings DL, Tokars JI, Abdel Aziz IZ, Alkhaldi KZ, Bensadek AT, Alraddadi BM, Jokhdar H, Jernigan JA, Garout MA, Tomczyk SM, Oboho IK, Geller AI, Arinaminpathy N, Swerdlow DL, Madani TA.

Emerg Infect Dis. 2016 May;22(5):794-801. doi: 10.3201/eid2205.151797.

12.

Clinicopathologic, Immunohistochemical, and Ultrastructural Findings of a Fatal Case of Middle East Respiratory Syndrome Coronavirus Infection in the United Arab Emirates, April 2014.

Ng DL, Al Hosani F, Keating MK, Gerber SI, Jones TL, Metcalfe MG, Tong S, Tao Y, Alami NN, Haynes LM, Mutei MA, Abdel-Wareth L, Uyeki TM, Swerdlow DL, Barakat M, Zaki SR.

Am J Pathol. 2016 Mar;186(3):652-8. doi: 10.1016/j.ajpath.2015.10.024. Epub 2016 Feb 5.

PMID:
26857507
13.

Salmonella enterica Infections in the United States and Assessment of Coefficients of Variation: A Novel Approach to Identify Epidemiologic Characteristics of Individual Serotypes, 1996-2011.

Boore AL, Hoekstra RM, Iwamoto M, Fields PI, Bishop RD, Swerdlow DL.

PLoS One. 2015 Dec 23;10(12):e0145416. doi: 10.1371/journal.pone.0145416. eCollection 2015.

14.

Risk Factors for Primary Middle East Respiratory Syndrome Coronavirus Illness in Humans, Saudi Arabia, 2014.

Alraddadi BM, Watson JT, Almarashi A, Abedi GR, Turkistani A, Sadran M, Housa A, Almazroa MA, Alraihan N, Banjar A, Albalawi E, Alhindi H, Choudhry AJ, Meiman JG, Paczkowski M, Curns A, Mounts A, Feikin DR, Marano N, Swerdlow DL, Gerber SI, Hajjeh R, Madani TA.

Emerg Infect Dis. 2016 Jan;22(1):49-55. doi: 10.3201/eid2201.151340.

15.

CDC's Early Response to a Novel Viral Disease, Middle East Respiratory Syndrome Coronavirus (MERS-CoV), September 2012-May 2014.

Williams HA, Dunville RL, Gerber SI, Erdman DD, Pesik N, Kuhar D, Mason KA, Haynes L, Rotz L, St Pierre J, Poser S, Bunga S, Pallansch MA, Swerdlow DL; MERS-CoV Working Group.

Public Health Rep. 2015 Jul-Aug;130(4):307-17.

16.

Net Costs Due to Seasonal Influenza Vaccination--United States, 2005-2009.

Carias C, Reed C, Kim IK, Foppa IM, Biggerstaff M, Meltzer MI, Finelli L, Swerdlow DL.

PLoS One. 2015 Jul 31;10(7):e0132922. doi: 10.1371/journal.pone.0132922. eCollection 2015.

17.

Lack of Transmission among Close Contacts of Patient with Case of Middle East Respiratory Syndrome Imported into the United States, 2014.

Breakwell L, Pringle K, Chea N, Allen D, Allen S, Richards S, Pantones P, Sandoval M, Liu L, Vernon M, Conover C, Chugh R, DeMaria A, Burns R, Smole S, Gerber SI, Cohen NJ, Kuhar D, Haynes LM, Schneider E, Kumar A, Kapoor M, Madrigal M, Swerdlow DL, Feikin DR.

Emerg Infect Dis. 2015 Jul;21(7):1128-34. doi: 10.3201/eid2107.150054.

18.

A change in vaccine efficacy and duration of protection explains recent rises in pertussis incidence in the United States.

Gambhir M, Clark TA, Cauchemez S, Tartof SY, Swerdlow DL, Ferguson NM.

PLoS Comput Biol. 2015 Apr 23;11(4):e1004138. doi: 10.1371/journal.pcbi.1004138. eCollection 2015 Apr.

19.

Potential demand for respirators and surgical masks during a hypothetical influenza pandemic in the United States.

Carias C, Rainisch G, Shankar M, Adhikari BB, Swerdlow DL, Bower WA, Pillai SK, Meltzer MI, Koonin LM.

Clin Infect Dis. 2015 May 1;60 Suppl 1:S42-51. doi: 10.1093/cid/civ141.

PMID:
25878300
20.

Estimating the United States demand for influenza antivirals and the effect on severe influenza disease during a potential pandemic.

O'Hagan JJ, Wong KK, Campbell AP, Patel A, Swerdlow DL, Fry AM, Koonin LM, Meltzer MI.

Clin Infect Dis. 2015 May 1;60 Suppl 1:S30-41. doi: 10.1093/cid/civ084.

21.

Estimating the potential effects of a vaccine program against an emerging influenza pandemic--United States.

Biggerstaff M, Reed C, Swerdlow DL, Gambhir M, Graitcer S, Finelli L, Borse RH, Rasmussen SA, Meltzer MI, Bridges CB.

Clin Infect Dis. 2015 May 1;60 Suppl 1:S20-9. doi: 10.1093/cid/ciu1175.

22.

Infectious disease modeling methods as tools for informing response to novel influenza viruses of unknown pandemic potential.

Gambhir M, Bozio C, O'Hagan JJ, Uzicanin A, Johnson LE, Biggerstaff M, Swerdlow DL.

Clin Infect Dis. 2015 May 1;60 Suppl 1:S11-9. doi: 10.1093/cid/civ083. Review.

23.

Standardizing scenarios to assess the need to respond to an influenza pandemic.

Meltzer MI, Gambhir M, Atkins CY, Swerdlow DL.

Clin Infect Dis. 2015 May 1;60 Suppl 1:S1-8. doi: 10.1093/cid/civ088. Review. No abstract available.

24.

2014 MERS-CoV outbreak in Jeddah--a link to health care facilities.

Oboho IK, Tomczyk SM, Al-Asmari AM, Banjar AA, Al-Mugti H, Aloraini MS, Alkhaldi KZ, Almohammadi EL, Alraddadi BM, Gerber SI, Swerdlow DL, Watson JT, Madani TA.

N Engl J Med. 2015 Feb 26;372(9):846-54. doi: 10.1056/NEJMoa1408636.

25.

Economic evaluation of typhoid vaccination in a prolonged typhoid outbreak setting: the case of Kasese district in Uganda.

Carias C, Walters MS, Wefula E, Date KA, Swerdlow DL, Vijayaraghavan M, Mintz E.

Vaccine. 2015 Apr 21;33(17):2079-85. doi: 10.1016/j.vaccine.2015.02.027. Epub 2015 Feb 21.

26.

Preparation of at-risk west African countries for Ebola.

Vora NM, Arthur RR, Swerdlow DL, Angulo FJ.

Lancet. 2015 Jan 24;385(9965):329-30. doi: 10.1016/S0140-6736(15)60118-0. No abstract available.

PMID:
25706851
27.

Middle East respiratory syndrome coronavirus: update for clinicians.

Rasmussen SA, Gerber SI, Swerdlow DL.

Clin Infect Dis. 2015 Jun 1;60(11):1686-9. doi: 10.1093/cid/civ118. Epub 2015 Feb 20.

28.

Update on the epidemiology of Middle East respiratory syndrome coronavirus (MERS-CoV) infection, and guidance for the public, clinicians, and public health authorities - January 2015.

Rha B, Rudd J, Feikin D, Watson J, Curns AT, Swerdlow DL, Pallansch MA, Gerber SI; Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2015 Jan 30;64(3):61-2.

29.

Enhancing disease surveillance with novel data streams: challenges and opportunities.

Althouse BM, Scarpino SV, Meyers LA, Ayers JW, Bargsten M, Baumbach J, Brownstein JS, Castro L, Clapham H, Cummings DA, Del Valle S, Eubank S, Fairchild G, Finelli L, Generous N, George D, Harper DR, Hébert-Dufresne L, Johansson MA, Konty K, Lipsitch M, Milinovich G, Miller JD, Nsoesie EO, Olson DR, Paul M, Polgreen PM, Priedhorsky R, Read JM, Rodríguez-Barraquer I, Smith DJ, Stefansen C, Swerdlow DL, Thompson D, Vespignani A, Wesolowski A.

EPJ Data Sci. 2015;4. pii: 17. doi: 10.1140/epjds/s13688-015-0054-0. Epub 2015 Oct 16.

30.

Swine flu in college: early campus response to outbreak control measures.

Mitchell T, Massoudi M, Swerdlow DL, Dee DL, Gould LH, Kutty PK, Prime MS, Silverman PR, Fishbein DB.

Am J Health Behav. 2014 May;38(3):448-64. doi: org/10.5993/AJHB.38.3.14.

PMID:
25181765
31.

Unraveling the mysteries of Middle East respiratory syndrome coronavirus.

Watson JT, Hall AJ, Erdman DD, Swerdlow DL, Gerber SI.

Emerg Infect Dis. 2014 Jun;20(6):1054-6. No abstract available.

32.

Hospital-associated outbreak of Middle East respiratory syndrome coronavirus: a serologic, epidemiologic, and clinical description.

Al-Abdallat MM, Payne DC, Alqasrawi S, Rha B, Tohme RA, Abedi GR, Al Nsour M, Iblan I, Jarour N, Farag NH, Haddadin A, Al-Sanouri T, Tamin A, Harcourt JL, Kuhar DT, Swerdlow DL, Erdman DD, Pallansch MA, Haynes LM, Gerber SI; Jordan MERS-CoV Investigation Team.

Clin Infect Dis. 2014 Nov 1;59(9):1225-33. doi: 10.1093/cid/ciu359. Epub 2014 May 14.

33.

First confirmed cases of Middle East respiratory syndrome coronavirus (MERS-CoV) infection in the United States, updated information on the epidemiology of MERS-CoV infection, and guidance for the public, clinicians, and public health authorities - May 2014.

Bialek SR, Allen D, Alvarado-Ramy F, Arthur R, Balajee A, Bell D, Best S, Blackmore C, Breakwell L, Cannons A, Brown C, Cetron M, Chea N, Chommanard C, Cohen N, Conover C, Crespo A, Creviston J, Curns AT, Dahl R, Dearth S, DeMaria A, Echols F, Erdman DD, Feikin D, Frias M, Gerber SI, Gulati R, Hale C, Haynes LM, Heberlein-Larson L, Holton K, Ijaz K, Kapoor M, Kohl K, Kuhar DT, Kumar AM, Kundich M, Lippold S, Liu L, Lovchik JC, Madoff L, Martell S, Matthews S, Moore J, Murray LR, Onofrey S, Pallansch MA, Pesik N, Pham H, Pillai S, Pontones P, Pringle K, Pritchard S, Rasmussen S, Richards S, Sandoval M, Schneider E, Schuchat A, Sheedy K, Sherin K, Swerdlow DL, Tappero JW, Vernon MO, Watkins S, Watson J; Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2014 May 16;63(19):431-6. Erratum in: MMWR Morb Mortal Wkly Rep. 2014 Jun 27;63(25):554.

34.

National patterns of Escherichia coli O157 infections, USA, 1996-2011.

Sodha SV, Heiman K, Gould LH, Bishop R, Iwamoto M, Swerdlow DL, Griffin PM.

Epidemiol Infect. 2015 Jan;143(2):267-73. doi: 10.1017/S0950268814000880. Epub 2014 Apr 14.

35.

Outbreak of type A foodborne botulism at a boarding school, Uganda, 2008.

Viray MA, Wamala J, Fagan R, Luquez C, Maslanka S, Downing R, Biggerstaff M, Malimbo M, Kirenga JB, Nakibuuka J, Ddumba E, Mbabazi W, Swerdlow DL.

Epidemiol Infect. 2014 Nov;142(11):2297-301. doi: 10.1017/S0950268814000387. Epub 2014 Feb 27.

36.

Stillbirth during infection with Middle East respiratory syndrome coronavirus.

Payne DC, Iblan I, Alqasrawi S, Al Nsour M, Rha B, Tohme RA, Abedi GR, Farag NH, Haddadin A, Al Sanhouri T, Jarour N, Swerdlow DL, Jamieson DJ, Pallansch MA, Haynes LM, Gerber SI, Al Abdallat MM; Jordan MERS-CoV Investigation Team.

J Infect Dis. 2014 Jun 15;209(12):1870-2. doi: 10.1093/infdis/jiu068. Epub 2014 Jan 28.

37.

Multiple contributory factors to the age distribution of disease cases: a modeling study in the context of influenza A(H3N2v).

Gambhir M, Swerdlow DL, Finelli L, Van Kerkhove MD, Biggerstaff M, Cauchemez S, Ferguson NM.

Clin Infect Dis. 2013 Jul;57 Suppl 1:S23-7. doi: 10.1093/cid/cit298.

38.

Transmissibility of variant influenza from Swine to humans: a modeling approach.

Wong KK, Gambhir M, Finelli L, Swerdlow DL, Ostroff S, Reed C.

Clin Infect Dis. 2013 Jul;57 Suppl 1:S16-22. doi: 10.1093/cid/cit303.

39.

Estimates of the number of human infections with influenza A(H3N2) variant virus, United States, August 2011-April 2012.

Biggerstaff M, Reed C, Epperson S, Jhung MA, Gambhir M, Bresee JS, Jernigan DB, Swerdlow DL, Finelli L.

Clin Infect Dis. 2013 Jul;57 Suppl 1:S12-5. doi: 10.1093/cid/cit273.

40.

The emergence of influenza A (H3N2)v virus: what we learned from the first wave.

Finelli L, Swerdlow DL.

Clin Infect Dis. 2013 Jul;57 Suppl 1:S1-3. doi: 10.1093/cid/cit324. No abstract available.

41.

Invasive pneumococcal disease and pandemic (H1N1) 2009, Denver, Colorado, USA.

Nelson GE, Gershman KA, Swerdlow DL, Beall BW, Moore MR.

Emerg Infect Dis. 2012 Feb;18(2):208-16. doi: 10.3201/eid1802.110714.

42.

Racial and ethnic disparities in hospitalizations and deaths associated with 2009 pandemic Influenza A (H1N1) virus infections in the United States.

Dee DL, Bensyl DM, Gindler J, Truman BI, Allen BG, D'Mello T, Pérez A, Kamimoto L, Biggerstaff M, Blanton L, Fowlkes A, Glover MJ, Swerdlow DL, Finelli L.

Ann Epidemiol. 2011 Aug;21(8):623-30. doi: 10.1016/j.annepidem.2011.03.002.

PMID:
21737049
43.

Influenza-like illness in a community surrounding a school-based outbreak of 2009 pandemic influenza A (H1N1) virus-Chicago, Illinois, 2009.

Janusz KB, Cortes JE, Serdarevic F, Jones RC, Jones JD, Ritger KA, Morita JY, Gerber SI, Gallagher L, Biggerstaff BJ, Hicks LA, Swerdlow DL, Fischer M, Staples JE; Chicago H1N1 Epidemiology Team.

Clin Infect Dis. 2011 Jan 1;52 Suppl 1:S94-101. doi: 10.1093/cid/ciq025.

44.

Serial intervals and the temporal distribution of secondary infections within households of 2009 pandemic influenza A (H1N1): implications for influenza control recommendations.

Donnelly CA, Finelli L, Cauchemez S, Olsen SJ, Doshi S, Jackson ML, Kennedy ED, Kamimoto L, Marchbanks TL, Morgan OW, Patel M, Swerdlow DL, Ferguson NM; pH1N1 Household Investigations Working Group.

Clin Infect Dis. 2011 Jan 1;52 Suppl 1:S123-30. doi: 10.1093/cid/ciq028.

45.

National outbreak of Salmonella serotype saintpaul infections: importance of Texas restaurant investigations in implicating jalapeño peppers.

Mody RK, Greene SA, Gaul L, Sever A, Pichette S, Zambrana I, Dang T, Gass A, Wood R, Herman K, Cantwell LB, Falkenhorst G, Wannemuehler K, Hoekstra RM, McCullum I, Cone A, Franklin L, Austin J, Delea K, Behravesh CB, Sodha SV, Yee JC, Emanuel B, Al-Khaldi SF, Jefferson V, Williams IT, Griffin PM, Swerdlow DL.

PLoS One. 2011 Feb 23;6(2):e16579. doi: 10.1371/journal.pone.0016579.

46.

Estimating the burden of 2009 pandemic influenza A (H1N1) in the United States (April 2009-April 2010).

Shrestha SS, Swerdlow DL, Borse RH, Prabhu VS, Finelli L, Atkins CY, Owusu-Edusei K, Bell B, Mead PS, Biggerstaff M, Brammer L, Davidson H, Jernigan D, Jhung MA, Kamimoto LA, Merlin TL, Nowell M, Redd SC, Reed C, Schuchat A, Meltzer MI.

Clin Infect Dis. 2011 Jan 1;52 Suppl 1:S75-82. doi: 10.1093/cid/ciq012.

PMID:
21342903
47.

Transmission of pandemic (H1N1) 2009 influenza to healthcare personnel in the United States.

Wise ME, De Perio M, Halpin J, Jhung M, Magill S, Black SR, Gerber SI, Harriman K, Rosenberg J, Borlaug G, Finelli L, Olsen SJ, Swerdlow DL, Kallen AJ.

Clin Infect Dis. 2011 Jan 1;52 Suppl 1:S198-204. doi: 10.1093/cid/ciq038.

PMID:
21342895
48.

Investigating 2009 pandemic influenza A (H1N1) in US schools: what have we learned?

Iuliano AD, Dawood FS, Silk BJ, Bhattarai A, Copeland D, Doshi S, France AM, Jackson ML, Kennedy E, Loustalot F, Marchbanks T, Mitchell T, Averhoff F, Olsen SJ, Swerdlow DL, Finelli L.

Clin Infect Dis. 2011 Jan 1;52 Suppl 1:S161-7. doi: 10.1093/cid/ciq032.

PMID:
21342889
49.

Non-pharmaceutical interventions during an outbreak of 2009 pandemic influenza A (H1N1) virus infection at a large public university, April-May 2009.

Mitchell T, Dee DL, Phares CR, Lipman HB, Gould LH, Kutty P, Desai M, Guh A, Iuliano AD, Silverman P, Siebold J, Armstrong GL, Swerdlow DL, Massoudi MS, Fishbein DB.

Clin Infect Dis. 2011 Jan 1;52 Suppl 1:S138-45. doi: 10.1093/cid/ciq056.

PMID:
21342886
50.

Viral shedding duration of pandemic influenza A H1N1 virus during an elementary school outbreak--Pennsylvania, May-June 2009.

Bhattarai A, Villanueva J, Palekar RS, Fagan R, Sessions W, Winter J, Berman L, Lute J, Leap R, Marchbanks T, Sodha SV, Moll M, Xu X, Fry A, Fiore A, Ostroff S, Swerdlow DL; Pennsylvania Working Group.

Clin Infect Dis. 2011 Jan 1;52 Suppl 1:S102-8. doi: 10.1093/cid/ciq026.

PMID:
21342880

Supplemental Content

Loading ...
Support Center